期刊文献+

Th17细胞在胸腺瘤合并MG发病机制中作用的探讨 被引量:2

The Roles of Th17 Cell in Pathogenesis of Thymoma with MG
下载PDF
导出
摘要 探讨Th17细胞在胸腺瘤合并重症肌无力(MG)发病中的作用。分析27例胸腺瘤患者相关资料,免疫组化法确定瘤组织中IL-17和CD4+T细胞表达。结果为胸腺瘤合并MG男性年龄低于女性,瘤组织高表达IL-17和CD4+T细胞。B1和B2型易合并MG。结论是Th17细胞和IL-17在胸腺瘤合并MG发病中有一定作用。 This article is to explore the roles of Th17 cell in the pathogenesis of Thymoma with Myasthenia Gravis(MG). A retrospective analysis of 27 cases of Thymoma for whom thymectomy were performed was made. The immunohistochemieai staining with IL--17 and CD4^+T was performed on the parrafined sections of the 27 Thymoma specimens. The average age of male Thymoma patients with MG was younger than the females. IL--17 and CD4^+ T cells were over--expressed in Thymoma tumor tissues in patients with MG. B1 and B2 type thymoma were more likely to be accompanied with MG. Th17 cells and IL--17 are important in pathogenesis for Thymoma with MG.
出处 《医学与哲学(B)》 2009年第10期56-58,63,共4页 Medicine & Philosophy(B)
关键词 重症肌无力 TH17细胞 胸腺瘤 myasthenia gravis, Th17, thymoma
  • 相关文献

参考文献2

二级参考文献19

  • 1毛海婷,王雄彪,张玲,顾洪涛.CTLA-4基因多态性在重症肌无力发病机理中的作用[J].中华医学遗传学杂志,2004,21(6):574-578. 被引量:13
  • 2方文涛,陈文虎,陈岗,何卫中,蒋勇.胸腺上皮肿瘤的外科治疗-204例临床病理分析[J].肿瘤,2005,25(4):377-380. 被引量:14
  • 3姬巍,冯勤富,周宗玫,汪楣,陈东福,张宏兴,肖泽芬,王绿化,殷蔚伯.73例胸腺癌的治疗与预后分析[J].中华放射肿瘤学杂志,2006,15(2):97-100. 被引量:8
  • 4史玉泉.实用神经病学[M].上海:上海科学技术出版社,1994.649-670.
  • 5Moran CA, Suster S. Thymic carcinoma: current concepts and histologic features[J]. Hematol Oncol Clin North Am, 2008,22(3) :393-407.
  • 6Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients[J]. Cancer, 2002, 94 (3) ;624-632.
  • 7Rena O, Papalia E, Maggi G, et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas [J]. Lung Cancer, 2005,50(1) ;59-66.
  • 8Rea F, Marulli G, Girardi R, et al. Long-term survival and prognostic factors in thymic epithelial tumours[J]. Eur J Cardiothorac Surg, 2004,26 (2) : 412-418.
  • 9Chen G, Marx A, Wen-Hu C, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China[J]. Cancer, 2002,95(2) :420- 429.
  • 10Park MS, Chung KY, Kim KD, et al. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification [J]. Ann Thorac Surg, 2004,78 (3);992-997. discussion 997- 998.

共引文献25

同被引文献35

  • 1Miyamoto M, Prause O, Sjostrand M, et al. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways [J]. Immunol, 2003, 170(9):4665-4672.
  • 2Kolls JK, Linden A. Interleukin-17 family members and inflammation[J]. Immunity, 2004, 21(4): 467-476.
  • 3Crellin NK, Garcia RV, Hadisfar O, et al. Human CD4^+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4^+ CD25^+T regulatory cells[J]. J Immunol, 2005, 175(12): 8051-8059.
  • 4Peng G, Guo Z, Kiniwa Y, et al. Toll-like receptor 8- mediated reversal of CD4^+ regulatory T cell function [J]. Science, 2005, 309(5739): 1380-1384.
  • 5Yang L, Anderson DE, Baecher Allan C, et al. IL-21 and TGF-beta are required for differentiation of human T (H) 17 cells[J]. Nature, 2008, 454(7202): 350-352.
  • 6Korn T, Bettelli E, Gao W, et al. IL ,21 initiates an alternative pathway to induce proinflammatory T(H) 17 cells[J]. Nature, 2007, 448(7152): 484-487.
  • 7Ivanov II, MeKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17^+ T helper cells [J]. Cell, 2006, 126(6): 1121-1133.
  • 8Brustle A, Heink S, Huber M, et al. The development of inflammatory T(H)-17 cells requires interfer on-regulatory factor 4[J]. Nat Immunol, 2007, 8(9): 958-966.
  • 9Romagnani S. Human Thl7 cells [J]. Arthritis Res Ther, 2008, 10(2): 206 -213.
  • 10Tzartos JS, Friese MA, Craner MJ, et al. In terleukin 17 production, in centra lnervous system infiltrating T cells and glial cells is associated with active disease in multiple sclerosis[J]. Am J Pathol, 2008, 172(1): 146-155.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部